Shares of Assura Plc (LON:AGR – Get Rating) have been assigned a consensus recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is GBX 79.83 ($0.97).
Several research analysts recently weighed in on the company. Peel Hunt reissued an “add” rating and set a GBX 85 ($1.03) price target on shares of Assura in a research report on Tuesday, May 24th. Berenberg Bank reaffirmed a “hold” rating and issued a GBX 80 ($0.97) price target on shares of Assura in a research note on Tuesday, May 31st. Barclays reaffirmed an “overweight” rating and issued a GBX 80 ($0.97) target price on shares of Assura in a research report on Monday, May 23rd. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 79 ($0.96) price target on shares of Assura in a report on Wednesday, May 25th. Finally, Shore Capital restated a “buy” rating on shares of Assura in a report on Tuesday, May 24th.
In other news, insider Jayne Cottam bought 700 shares of the business’s stock in a transaction on Tuesday, May 31st. The stock was purchased at an average price of GBX 71 ($0.86) per share, with a total value of £497 ($603.23). Insiders purchased a total of 1,138 shares of company stock worth $79,658 in the last quarter.
The company also recently announced a dividend, which will be paid on Wednesday, July 13th. Investors of record on Thursday, June 9th will be paid a GBX 0.78 ($0.01) dividend. The ex-dividend date is Thursday, June 9th. This is a positive change from Assura’s previous dividend of $0.74. This represents a yield of 1.14%. Assura’s dividend payout ratio (DPR) is presently 0.53%.
Assura Company Profile (Get Rating)
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.
- Ride Out The Recession With These Dividend Kings
- MarketBeat: Week in Review 6/13 – 6/17
- eBay’s Long Term Fundamentals Are Intact If You Can Stomach Short Term Volatility
- Honda’s Stock Continues To Fly Under The Radar
- Vuzix Stock Stays Optimistic
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.